Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases

Free Radical Biology and Medicine

Volumn 111, Issue , 2017, Pages 110-126

  Zarkovic, Kamelija ^a   Jakovcevic, Antonia ^a   Zarkovic, Neven ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

4 Hydroxy 2 nonenal (HNE); Disease; Immunohistochemistry; Lipid peroxidation; Monoclonal antibodies; Oxidative stress; Pathology; Pathophysiology

Indexed keywords

4 HYDROXYNONENAL; HISTIDINE; 4-HYDROXY-2-NONENAL; ALDEHYDE; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; UNSATURATED FATTY ACID;

AGING; BONE CELL; BONE GROWTH; BRAIN TUMOR; BREAST CARCINOMA; CARDIOVASCULAR DISEASE; CELL GROWTH; CENTRAL NERVOUS SYSTEM; COLON CARCINOGENESIS; CUTANEOUS PARAMETERS; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; LIVER CARCINOGENESIS; LIVER DISEASE; LUNG CANCER; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THYROID TUMOR; ANIMAL; CHEMISTRY; DEGENERATIVE DISEASE; LIPID PEROXIDATION; LUNG DISEASE; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PATHOLOGY;

ALDEHYDES; AMYLOID BETA-PEPTIDES; ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LUNG DISEASES; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TAU PROTEINS;

EID: 85008622650     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.12.009     Document Type: Review

References (216)

1. Esterbauer, H., Schaur, R.J., Zolner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehide and related aldehides. Free Radic. Biol. Med. 11 (1991), 81–128.
2. Uchida, K., Kanematsu, Y., Osawa, T., Noguchi, N., Niki, E., Acrolein is a product of lipid peroxidation. formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998), 16058–16066.
3. Uchida, K., Toyokuni, S., Nishikawa, K., Kavakishi, S., Oda, H., Hirai, H., Stadtman, E.R., Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers of atherosclerosis. Biochemistry 33 (1994), 12487–12494.
4. Humphries, K.M., Szweda, L.I., Selective inactivation of alpha-ketoglutarat dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37 (1998), 15835–15841.
5. Musatov, A., Carrol, C.A., Liu, Y., Henderson, G.I., Weintraub, S.T., Robinson, N.C., Identification of bovine hart cytocrome c oxidase subunit modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 41 (2002), 8212–8220.
6. Negre-Salvayre, A., Viera, O., Escargueil- Blanc, I., Salvayre, R., Oxidized LDL and 4-hydroxynonenal modulate tyrosin kinase receptor activity. Mol. Asp. Med. 24 (2003), 251–261.
7. Uchida, K., 4-hydroxy-2-nonenal a product and mediator of oxidative stress. Prog. Lipid Res. 42 (2003), 318–343.
8. Kaphahn, R.J., Giwa, B.M., Berg, K.M., Roehrich, H., Feng, X., Olsen, T.W., Ferrington, D.A., Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp. Eye Res. 83 (2006), 165–175.
9. Spickett, C.M., Wiswedel, I., Werner, S., Zarkovic, K., Zarkovic, N., Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic. Res. 44 (2010), 1172–1202.
10. Gasparovic, A.C., Jaganjac, M., Mihaljevic, B., Sunjic, S.B., Zarkovic, N., Assays for the measurement of lipid peroxidation. Methods Mol. Biol. (Clifton, N. J.) 965 (2013), 283–296.
11. Palinski, W., Rosenfeld, M.E., Yla-Herttuala, S., Gurtner, G.C., Socher, S.S., Butler, S.W., Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. Usa. 86 (1989), 1372–1376.
12. Chen, Q., Esterbauer, H., Jurgens, G., Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. biochemical characterization and determination. Biochem. J. 288 (1992), 249–254.
13. Uchida, K., Toyokuni, S., Nishikawa, K., Kawakishi, S., Oda, H., Hiai, H., Stadtmen, E.R., Michael addition-type 4hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33 (1994), 12487–12494.
14. Wakita, C.I., Honda, K., Shibata, T., Akagawa, M., Uchida, K., A method for detection of 4-hydroxy-2-nonenal adducts in proteins. Free Radic. Biol. Med. 51 (2011), 1–4.
15. Uchida, K., Itakura, K., Kawakishi, S., Hiai, H., Toyokuni, S., Stadtman, E.R., Characterization of epitopes recognized by 4-hyddroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324 (1995), 241–248.
16. Toyokuni, S., Miyake, N., Hiai, H., Hagiwara, M., Kawakishi, S., Osawa, T., Uchida, K., The monoclonal antibody specific for 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 359 (1995), 189–191.
17. Waeg, G., Dimsity, G., Esterbauer, H., Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free. Radic. Res. 25 (1996), 149–159.
18. Sovic, A., Borovic, S., Loncaric, I., Kreuzer, T., Zarkovic, K., Vukovic, T., Wäeg, G., Hrascan, R., Wintersteiger, R., Klinger, R., Zurak, N., Schaur, R.J., Zarkovic, N., The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res. 21 (2001), 1997–2004.
19. Borovic, S., Rabuzin, F., Waeg, G., Zarkovic, N., Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic. Res. 40 (2006), 809–820.
20. Weber, D., Milkovic, L., Bennett, S.J., Griffiths, H.R., Zarkovic, N., Grune, T., Measurement of HNE protein adducts in human plasma and serum by ELISA - Comparison of two primary antibodies. Redox Biol. 1 (2013), 223–226.
21. Frijhoff, J., Winyard, P.G., Zarkovic, N., Davies, S., Stocker, R., Cheng, D., Knight, A., Taylor, E.L., Oettrich, J., Ruskovska, T., Cipak Gasparovic, A., Cuadrado, A., Weber, D., Poulsen, H.E., Grune, T., Schmidt, H.H., Ghezzi, P., Clinical relevance of biomarkers of oxidative stress. Antioxid. Redox Signal. 23 (2015), 1144–1170.
22. Sayre, L.M., Sha, W., Xu, G., Kaur, K., Nadkarni, D., Subbanagounder, G., Salomon, R.G., Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9 (1996), 1194–1201.
23. Tsai, L., Szweda, P.A., Vinogradova, O., Szweda, L.I., Structural characterization and immunochemical detection of fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc. Natl. Acad. Sci. USA 95 (1998), 7975–7980.
24. Itakura, K., Oya-Ito, T., Osawa, T., Yamada, S., Toyokuni, S., Shibata, N., Kobayashi, M., Uchida, K., Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-Hydroxy-2-nonenal as a potential source of fluorescent chromophore. FEBS Lett. 473 (2000), 249–253.
25. Astrup, J., Siesjo, B.K., Symon, L., Tresholds in cerebral ishemia- the ishemic penumbra. Stroke, 12, 1981, 725 (725).
26. Dirnagl, I., Iadocola, C., Moskowitz, M.A., Pathobiology of ischaemic shock: an integrated view. Trends Neurosci. 22 (1999), 391–397.
27. Chan, P.H., Role of oxidants in ischemic brain damage. Stroke 27 (1996), 1124–1129.
28. Hoffman, W.H., Siedalak, S.L., Wang, Y., Castellani, R.J., Smith, M.A., Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 1369 (2010), 194–202.
29. Biegon, A., Canabinoids as neuroprotective agents in traumatic brain injury. Curr. Pharm. Des. 10 (2004), 2177–2183.
30. Ansari, M.A., Roberts, K.N., Scheff, S.W., Oxidative stress and modification of synaptic proteins in hippocampus after traumatic injury. Free Radic. Biol. Med. 43 (2008), 443–452.
31. Cooper, P., Central nervous system trauma status report. Povlishhok, J., Backer, D., (eds.) Delayed brain injury, 1985, National Institutes of Health, Washington DC, 217–282.
32. Springer, J.E., Azbil, R.D., Mark, R.J., Begley, J.G., Waeg, G., Mattson, M.P., 4-hydroxynonenal, a lipid peroxidation product, rapidli accumulates following traumatic spinal cord injury and inhibits glutamat uptake. J. Neurochem. 68 (1997), 2469–2476.
33. Luo, J., Uchida, K., Shi, R., Accumulation of acrolein-protein adducts after traumatic spinal injury. Neurochem. Res. 30 (2005), 291–295.
34. Subramaniam, R., Roediger, F., Jordan, B., Mattson, M.P., Kellaer, J.N., Waeg, G., Buterfield, D.A., The lipid peroxidation product 4-hydroxy-2-trans- nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem. 69 (1997), 1161–1169.
35. McCracken, E., Valeriani, V., Simpson, C., Jover, T., McCulloch, J., Dewer, D., The lipid peroxidation by-products 4-hydroxynonenal is toxic to axons and oligodendrocyte. J. Cereb. Blood Flow Metab. 20 (2000), 1529–1536.
36. Mahad, D., Ziabreva, I., Lassman, H., Turnbull, D., Mitochondrial defect in acute multiple sclerosis lesion. Brain 131 (2008), 1722–1735.
37. Marik, C., Felts, P., Bauer, J., Lassman, H., Smith, K.J., Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 130 (2007), 2800–2815.
38. Henderson, A.P.D., Barnet, M.H., Parratt, J.D.E., Prineas, J.W., Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol., 66(739), 2009, 753.
39. Chang, M.K., Binder, C.J., Miller, Y.I., Subbanagounder, G., Silverman, G.J., Beliner, J.A., Appoptotic cell with oxidation specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200 (2004), 1359–1370.
40. Heider, L., Fischer, M., Fischer, J.M., Bauer, J., Hoeftbarg, R., Boton, G., Esterbauer, H., Binder, C.J., Witztum, J.L., Lassman, H., Oxidative damage in multiple sclerosis lesion. Brain 134 (2011), 1914–1924.
41. Babior, M.B., Phagocites and oxidative stress. Am. J. Med. 109 (2000), 33–44.
42. Leto, T.L., Morand, S., Hurt, D., Uveyema, T., Targeting and regulation of reactive oxigen species by Nox family NADPH oxidases. Antioxid. Redox Signal. 11 (2009), 2607–2619.
43. Hanley, P.J., Musset, B., Reigunta, V., Limberg, S.H., Dalpke, A.H., Sus, R., Heeg, K.M., Preisig-Miller, R., Daut, J., Extracellular ATP induces oscillation of intracellular Ca2+ and membrane potential and promotes of IL-6 in macrophages. Proc. Natl. Acad. Sci. USA 101 (2004), 9479–9484.
44. Zarkovic, K., Zarkovic, N., Schlag, G., Redl, H., Waeg, G., Histological aspects of sepsis-induced brain changes in a baboon model. Schlag, G., Redl, H., Traber, D., (eds.) Shock, sepsis and organ failure-brain damage –traumatic shock, sepsis and traumatic brain injuty (Fifth Wiggers Bernard conference 1996), 1996, Springer-Verlag, Berlin, 146–164.
45. Zarkovic, N., Zarkovic, K., Schaur, R.J., Stolc, S., Schlag, G., Redl, H., Waeg, G., Borovic, S., Loncaric, I., Juric, G., Hlavka, V., 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci. 65 (1999), 1901–1904.
46. Rojo, A.I., McBean, G., Cindric, M., Egea, J., López, M.G., Rada, P., Zarkovic, N., Cuadrado, A., Redox control of microglial function: molecular mechanisms and functional significance. Antioxid. Redox Signal. 21 (2014), 1766–1801.
47. Sayr, L.M., Smith, M.A., Perry, G., Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8 (2001), 721–738.
48. Huyakava, N., Yokoyama, H., Kato, H., Araki, T., Age related alteration of oxidative stress in the mouse hippocampal CA1 sector. Exp. Mol. Path. 85 (2008), 135–140.
49. Srividhya, R., Zarkovic, K., Stroser, M., Waeg, G., Zarkovic, N., Kalaiselvi, P., Mitochondrial alterations in aging rat brain: effective role of (-)-epigallo catechin gallate. Int. J. Devl. Neurosci. 27 (2007), 223–231.
50. Papaioannou, N., Tooten, P.C.J., van Ederen, A.M., Bohl, J.R.E., Rofina, J., Tsangaris, T., Gruys, E., Immunohistochemical investigation of the brain of aged dogs- I. detection of neurofibrillary tangles and of 4-hydroxinonenal protein, an oxidative damage product, in senile plaques. Amyloid. J. Protein Fold Disord. 8 (2001), 11–21.
51. Ando, Y., Branstrom, T., Uchida, K., Nyhlin, N., Nasman, B., Suhr, O., Yamashit, T., Olsson, T., El Salhy, M., Uchino, M., Ando, M., Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J. Neurol. Sci. 156 (1998), 172–176.
52. Jorm, A.F., Jolley, D., The incidence of dementia: a meta-analysis. Neurology 51 (1998), 728–733.
53. Price, D.L., Sisodia, S.S., Gandy, S.E., Amyloid beta amyloidosis in Alzheimer's disease. Curr. Opin. Neurol. 8 (1995), 268–274.
54. Shringarpure, R., Grune, T., Sitte, N., Davies, K.J., 4-hydroxinonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell. Mol. Life Sci. 57 (1995), 1802–1809.
55. Morrow, J.D., Roberts, L.J., The isoprostanes. unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36 (1997), 1–21.
56. Lovell, M.A., Ehmann, W.D., Butler, S.M., Markesbery, W.R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45 (1995), 1594–1601.
57. Keller, J.N., Pang, Z., Geddes, J.W., Begley, J.G., Germeyer, A., Waeg, G., Mattson, M.P., Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69 (1997), 273–284.
58. Bruce-Keller, A.J., Lt, Y.J., Lovell, M.A., Kraemer, P.J., Gary, D.S., Brown, R.R., Markesbery, W.R., Mattson, M.P., Hydroxynonenal a product of lipid peroxidation, damages cholinergic neurons and impairs visuospstial memory in rats. J. Neuropathol. Exp. Neurol. 57 (1998), 257–267.
59. Kruman, I., Bruce-Keler, A.J., Bredesen, D., Waeg, G., Mattson, M.P., Evidence that 4-hydroxynonenyl mediates oxidative stress- induced neuronal apoptosis. J. Neurosci. 17 (1997), 5089–5100.
60. Markesbery, W.R., Lovell, M.A., Four-hydroxynonenal a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998), 33–36.
61. Bradley, M.A., Markesbey, W.R., Lovell, M.A., Increased levels of 4-hydroxinonenal and acrolein in the brain preclinical Alzheimer disease. Free Radic. Biol. Med. 48 (2010), 1570–1576.
62. Smith, M., Hirai, K., Hsiao, K., Pappola, M.A., Harris, P.L.R., Sieadlak, S.L., Tabaton, M., Perry, G., Amiloid –b deposition in Alzheimer transgenic mice is associated with oxidativea stres. J. Neurochem. 70 (1998), 2212–2215.
63. Odetti, P., Garibaldi, S., Norese, R., Angelini, G., Marinelli, L., Valentini, S., Menini, S., Traverso, N., Zaccheo, D., Siedlak, S., Perry, G., Smith, M.A., Tabaton, M., Lipoperoxidation is selectively involved in progressive supranuclear palsy. J. Neuropath. Exp. Neurol. 59 (2000), 393–397.
64. Montine, T.J., Amarnath, V., Martin, M.E., Strittmatter, W.J., Graham, D.G., 4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148 (1996), 89–93.
65. Montine, T.J., Huang, D.Y., Valentine, W.M., Amarnath, V., Saundrs, A., Weisgraber, K.H., Graham, D.G., Strittmatter, W.J., Crosslinking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol. 55 (1996), 202–210.
66. Danielson, U.H., Esterbauer, H., Mannervik, B., Stricture-activity relationship of 4-hidroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem. J. 247 (1987), 707–713.
67. Lovell, M.A., Markesbery, W.R., Decrease glutathion transferase in brain and ventricular fluid in Alzheimer's disease. Neurology 51 (1998), 1561–1566.
68. Marnett, L.J., DNA adducts of α, β-unsaturated aldehydes and dicarbonyl compounds. IARC Sci. Publ. 125 (1994), 151–163.
69. Lovell, M.A., Xie, C., Markesbery, W.R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal culture. Neurobio. Aging 22 (2001), 187–194.
70. Haenen, G.R., Vermeulen, N.P., Tai Tin Tsoi, J.N., Ragetli, H., Timmerman, H., Blast, A., Activation of the microsomal glutathion-S transferase and reduction of the glutathion dependent protection against lipid peroxidation by acrolein. Biochem. Pharmacol. 37 (1988), 1933–1938.
71. Uchida, K., Kanematsu, Y., Osawa, T., Noguchi, N., Niki, E., Acrolein is a product of lipid peroxidation, formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998), 16058–16066.
72. Calingasan, N.Y., Uchida, K., Gibson, G.E., Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72 (1999), 751–756.
73. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., Oregan, J.P., Deng, H.X., Rahmani, Z., Krizus, A., McKennayasek, D., Cayabyab, A., Gaston, S.M., Berger, R., Tanzi, R.E., Halperin, J.J., Herzfeldt, B., Vanderbergh, R., Hung, W.Y., Bird, T., Deng, G., Mulder, D.W., Smyth, C., Laing, N.G., Soriano, E., Pericakvance, M.A., Haine, J., Rouleau, G.A., Gusella, J.S., Horvitz, H.R., Brown, R.H., Mutation in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993), 59–62.
74. Borchelt, D.R., Lee, M.K., Slunt, H.S., Guarnier, M., Xu, Z.S., Wong, P.C., Brown, R.H., Price, D.L., Sisodia, S.S., Cleveland, D.W., Superoxid dismutase-1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Nat. Acad. Sci. USA. 91 (1994), 8292–8296.
75. Beckman, J.S., Carson, M., Smith, C.D., Koppenol, W.H., ALS, Sod and peroxynitrite. Nature, 364, 1993, 584.
76. Shibata, N., Hirano, A., Kobayashi, M., Siddique, T., Deng, H.X., Hing, W.Y., Kato, T., Asayama, K., Intense superoxide dismutas-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropath. Exp. Neurol. 55 (1996), 481–490.
77. Pedersen, W.A., Cashman, N.R., Mattson, M.P., The lipid peroxidation product 4-hydroxynonenal impairs glutamat and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp. Neurol. 155 (1999), 1–10.
78. Pedersen, W.A., Fu, W., Keller, J.N., Markesbery, W.R., Appel, Smith, R.G., Kasarkis, E., Mattson, M.P., Protein modification by the lipid peroxidation product 4-hydroxynonenal I the spinal cord of amyotrophic lateral sclerosis patients. Ann. Neurol. 44 (1998), 819–824.
79. Shibata, N., Nagai, R., Miyata, S., Jono, T., Horiuchi, S., Hirano, A., Kato, S., Sasaki, S., Asayama, K., Kobayashi, M., Non oxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropatol. 100 (2000), 275–284.
80. Ferrante, R.J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W., Brown, R., Hjr, Beal, M.F., Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69 (1997), 2064–2074.
81. Mc Naught, K.S., Belizaire, R., Jenner, P., Olanov, C.W., Isacson, O., Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Perkinsons disease. Neurosci. Lett. 326 (2002), 155–158.
82. Sofic, E., Paulus, W., Jellinge, K., Riederer, P., Youdim, M.B., Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56 (1991), 978–982.
83. Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jellinger, K.A., Youdim, M.B., Transition metals, ferritin, gluthatione, and ascorbic in parkinsonian brains. J. Neurochem. 52 (1989), 515–520.
84. Khan, F.H., Saha, M., Chakrabarti, S., Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain. Brain Res. 895 (2001), 245–249.
85. Zhang, J., Perry, G., Smith, M.A., Robertson, D., Olson, S.J., Graham, D.G., Montine, T.J., Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154 (1999), 1423–1429.
86. Alam, Z., Jenner, A., Daniel, S.E., Lees, A.J., Cairns, N., Marsden, D.C., Jenner, P., Halliwell, B., Oxidative DNA damage in the parkinsonian brain: apparent selective increase in 8-hydroxyguanine level in substantia nigra. J. Neurochem. 69 (1997), 1196–1203.
87. Giasson, B.I., Duda, J.E., Murray, I.V., Chen, Q., Souza, J.M., Hurtig, H.I., Ischiropoulos, H., Trojanovski, J.Q., Lee, V.M., Oxidative damage linked to neurodegeneration by selective alpha synuclein nitration in synleucopthy lesions. Science 290 (2000), 985–989.
88. Castellani, R.J., Perry, G., Siedlak, S.L., Nunomura, A., Shimohama, S., Zhang, J., Montine, T., Sayre, L.M., Smith, M.A., Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci. Lett. 319 (2002), 25–28.
89. Shibata, N., Inose, Y., Toi, S., Hiroi, A., Yamamoto, T., Kabayashi, M., Involvement of 4-hyrdoxy −2.nonenal accumulation in multiple system atrophy. Acta Histochem. Cytochem. 43 (2010), 69–75.
90. Zarkovic, N., Ilic, Z., Jurin, M., Scahur, R.J., Puhl, H., Esterbauer, H., Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem. Funct. 11 (1993), 279–286.
91. Zarkovic, N., 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol. Asp. Med. 24 (2003), 281–291.
92. Hwang, I.K., Kim, I.Y., Kim, Y.N., Yoo, K.Y., Kim, Y.N., Yi, S.S., Park, I.S., Min, B.H., Doo, H.K., Ahn, S.Y., Kim, Y.S., Lee, Y.S., Yoon, Y.S., Seong, Y.K., Comparative study on high fat diet –induced 4-hydoxi-2E-nonenal adducts in the hippocampus CA1 region of C57BL/6N and C3H/hen mice. Neurochem. Res. 34 (2009), 964–972.
93. Park, H.R., Park, M., Choi, J., Park, K.J., Chung, H.Y., Lee, J., A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain –derived neurotrophic factor. Neurosci. Lett. 482 (2010), 235–239.
94. Zarkovic, K., Juric, G., Waeg, G., Kolenc, D., Zarkovic, N., Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas. BioFactors 24 (2005), 33–40.
95. GJS Juric-Sekhar, G., Zarkovic, K., Waeg, G., Cipak, A., Žarkovic, N., Distribution of 4-hydroxynonenal-proteinconjugates as a marker of lipid peroxidation and parameter of malignancy in astrocyticand ependymal tumors of the brain. Tumori 95 (2009), 762–768.
96. Kolenc, D., Jakovcevic, A., Macan, M., Zarkovic, K., The co-expression of 4-hydroxynonenal and prominin-1 in glioblastomas. Transl. Neurosci. 2 (2011), 163–167.
97. Cipak, A., Mrakovcic, L., Ciz, M., Lojek, A., Mihaylova, B., Goshev, I., Jaganjac, M., Cindric, M., Sitic, S., Margaritoni, M., Waeg, W., Balic, M., Zarkovic, N., Growth suppression of human breast carcinoma stem cells by lipid peroxidation product 4-hydroxy-2-nonenal and hydroxyl radical- modified collagen. Acta Biochim. Pol. 57 (2010), 165–171.
98. Bauer, G., Zarkovic, N., Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase. Free Radic. Biol. Med. 81 (2015), 128–144.
99. Steinberg, D., Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272 (1997), 20963–20966.
100. Heinecke, J.W., Mechanism of oxidative damage of low-density lipoproteine in human atherosclerosis. Curr. Opin. Lipidol. 8 (1997), 268–274.
101. G. Virella, D.H. Atchely, S. Koskinen, D. Zheng, M. Lopes-VirellaPro-atherogenic and pro-inflammatory properties of immune complex prepared with purified human oxLDL antibodies and human oxJDL. Clin. Immunolo.105:81-92; 1002.
102. Steinbrecher, U.P., Receptors for oxidized low density lipoprotein. Biochem. Biophys. Acta 1436 (1990), 279–298.
103. Brown, B.E., Dean, R.T., Davies, M.J., Glycation of low-density lipoproteins by methilglyoxal and flycolaldehyde gives rise to the in vitro formation of lipid-laden cells. Diabetologia 48 (2005), 361–369.
104. Jurgens, G., Esterbauer, H., Mair, S., Ledinski, G., Dinges, H.P., Imunostaining oh human autopy aortas with antibodies to modifier apolipoprotein B and apoprotein(a). Atheroscler. Thromb. 13:11 (1993), 1589–1699.
105. Chen, J.J., Bertrand, H., Yu, B.P., Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free. Radic. Biol. Med. 19 (1995), 583–590.
106. Palinski, W., Rosenfeld, M.E., Yla- Hertulla, S., Gurtner, G.C., Socher, S.S., Butler, S.W., Parthasarathy, S., Carew, T.E., Steinberg, D., Witztum, J.L., Low density lipoprotein undergoes oxidative modification in vitro. Proc. Nat. Acad. Sci. USA 86 (1989), 1372–1376.
107. Fredrikson, G.N., Berglund, G., Alm, R., Nilsson, J.A., Shah, P.K., Nilsson, J., Identification of autoantibodies in human plasma recognized an apoB-100 LDL receptor binding site peptide. J. Lipid Res. 47 (2006), 2049–2054.
108. Fraley, A.E., Tsimikas, S., Clinical application of circulating oxidized low-density lipoprotein biomarker in cardiovascular disease. Curr. Opin. Lipidol. 17 (2006), 501–509.
109. Olson, M., Thyberg, J., Nilsson, J., Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Atheroscler. Thromb. Vasc. Biol. 19 (1999), 1218–1222.
110. Mitjavila, M.T., Casos, K., Zaragoza, M., Zarkovic, N., Zarkovic, K., Portero-Otin, M., A fish oil-rich diet reduces vascular oxidative stress in apoE-/-mice. Free Radic. Res. 44:7 (2010), 821–829.
111. Sanson, M., Auge, N., Vindis, C., Muller, C., Bando, Y., Thiers, J.C., Marachet, M.A., Zarkovic, K., Sawa, Y., Salvayer, R., Negre-Salvayre, A., Oxidized low-denzity lipoproteins trigger endoplastic reticulum stress in vascular cells: prevention by oxygen regulated protein 150 expresion. (13) Circ. Res. 104:3 (2009), 328–336.
112. Cavalcante, J.L., Lima, J.A., Redheuil, A., Al-Mallah, M.H., Aortic stiffness: current understanding and future direction. J. Am. Coll. Cardiol. 57 (2011), 1511–1522.
113. Bilato, C., Crow, M.T., Atherosclerosis and the vascular biology of aging. Aging 8 (1996), 221–234.
114. Tamarina, N.A., McMillan, W.D., ShLiveli, V.P., Pearce, W.H., Expression of matrix metalloprotinases and their inhibitors in aneurysms and normal aorta. Surgery 122 (1997), 264–271.
115. Kovacic, J.C., Moreno, P., Nabel, E.G., Hachinski, V., Fuster, V., Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation 123:17 (2011), 1900–1910.
116. Lee, A.T., Cerami, A., Role of glycation in aging. Ann. N. Y. Acad. Sci. 663 (1992), 63–70.
117. Bailey, A.J., Molecular mechanisms of ageing in connective tissues. Mech. Ageing Dev. 122:7 (2001), 735–755.
118. Konova, E., Baydanoff, Atanasova, M., Velkova, A., Age-related changes in the glycation of human aortic elastin. Exp. Gerontol. 39:2 (2004), 249–254.
119. Zieman, S.J., Melenovsky, V., Kass, D.A., Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25:5 (2005), 932–943.
120. Negre-Salvayre, A., Auge, N., Ayala, V., et al. Pathological aspects of lipid peroxidation. Free Radic. Res. 44:10 (2010), 1125–1171.
121. Zarkovic, K., Larroque- Cardoso, P., Pucelle, M., Salvayere, R., Waeg, G., Negre-Salvayre, A., Zarkovic, N., Elasin aging and lipid oxidation products in human aorta. Redox Biol. 4 (2015), 109–117.
122. Tanaka, N., Tajima, S., Ishibasci, A., Uchida, K., Sigematsu, T., Immunohistochemical detection of lipid peroxidation productes protein-bound acrolein and 4-hydroxynonenal protein adducts, in actinic elastosis of photodamaged skin. Arcg. Dermathol. Res. 293 (2001), 363–367.
123. Berneburg, M., Pletenberg, H., Krutman, J., Protoaging of human skin. Photodermatol. Fotoimunol. Pfotomed. 16 (2000), 239–244.
124. Kang, S., Fisher, G.J., Voorhees, J.J., Photoaging: pathogenesis prevention and treatment. Clin. Geriatr. Med. 17 (2001), 643–659.
125. Jagdeo, J., Adams, L., Lev-Tov, H., Sieminska, J., Michl, J., Brody, N., Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro. J. Drugs Dermatol. 9:12 (2010), 1523–1526.
126. Jagdeo, J., Brody, N., Complementary antioxidant function of caffeine and green tea polyphenols in normal human skin fibroblasts. J. Drugs Dermatol. 10:7 (2011), 753–761.
127. Silverberg, J.I., Jagdeo, J., Patel, M., Siegel, D., Brody, N., Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis. J. Drugs Dermatol. 10 (2011), 1096–1101.
128. Silverberg, J.I., Patel, M., Brody, N., Jagdeo, J., Caffeine protects human skin fibroblasts from acute reactive oxygen species-induced necrosis. J. Drugs Dermatol. 11:11 (2012), 1342–1346.
129. Witz, G., Active oxygen species as factors in multistage carcinogenesis. Proceedings of the Society for Experimental biology and medicine. Soc. Exp. Biol. Med. 198 (1991), 675–682.
130. Uchida, K., 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42:4 (2003), 318–343.
131. Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S., Loeb, L.A., 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G—-T and A—-C substitutions. J. Biol. Chem. 5 (1991), 166–172.
132. Matsumura, Y., Ananthaswamy, H.N., Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev. Mol. Med. 4:26 (2002), 1–22.
133. Morliere, P., Moysan, A., Tirache, I., Action spectrum for Uv-induced lipid-peroxidation in cultured human skin fibroblasts. Free Radic. Biol. Med. 19 (1995), 365–371.
134. Katiyar, S.K., Afaq, F., Perez, A., Mukhtar, H., Green tea polyphenol (−)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22 (2001), 287–294.
135. Shindo, Y., Witt, E., Han, D., Packer, L., Dose-Response Effects of Acute Ultraviolet-Irradiation on Antioxidants and Molecular Markers of Oxidation in Murine Epidermis and Dermis. J. Invest Dermatol. 102 (1994), 470–475.
136. Williams, J.D., Bermudez, Y., Uchida, K., Hurst, C.A., Wondrak, G.T., Malondialdehyde-derived epitopes in human skin result from acute exposure to solar UV and occur in nonmelanoma skin cancer tissue. J. Photochem. Photobiol. B. 5:132 (2014), 56–65.
137. Mamalis, A., Fiadorchanka, N., Adams, L., Heilman, E., Siegel, D., Brody, N., Jagdeo, J., An immunohistochemical panel to assess ultraviolet radiation associated oxidative skin injury. J. Drugs Dermatol. 13:5 (2014), 574–578.
138. Larroque-Cardoso, P., Camare, C., Nadal-Wolbold, F., Grazide, M.H., Pucelle, M., Garobi-Salom, S., Bogranowicz, P., Josse, G., Schmitt, A.M., Uchida, K., Žarković, K., Salvayare, R., Negre-Salvayre, A., Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic Elastosis. J. Ivestigative Dermathol. 135 (2015), 1873–1881.
139. Larroque -Cardoso, P., Mucher, E., Grazide, M.H., Josse, G., Schmitt, A.M., Nadal-Wolbold, F., Zarkovic, K., Salvayere, R., Negre-Salvayre, A., 4-hydroxynonenal impairs TGF-b1 induced elastin synthesis via EGFR activation in human and murine fibroblast. Free Radic. Biol. Med. 71 (2014), 427–436.
140. Cortez-Pinto, H., Oxidative stress in alcoholic and nonalcoholic liver disease. Leuchster, U., James, O.F.W., Dancygier, M., (eds.) Falc symposium 121. Steatohepatitis (NASH and ASH), 2001, Kluver Academic Publisher, Dordrecht, 54–61.
141. Lai, M.M., Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroentherology 122 (2002), 568–571.
142. Anzenbacher, P., Anzenbacherova, E., Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life. Sci. 58:5–6 (2001), 737–747.
143. Day, C.P., Pathogenesis of steatohepatitis. Best. Pract. Res. Clin. Gastroenterol. 16 (2002), 663–678.
144. de Knegt, R.J., Non-alcoholic steatohepatitis: clinical significance and pathogenesis. Scand. J. Gastroenterol. Suppl. 234 (2001), 88–92.
145. Reid, A.E., Nonalcoholic steatohepatitis. Gastroenterology 121:3 (2001), 710–723.
146. Loguercio, C., De Girolamo, V., de Sio, I., Tuccillo, C., Ascione, A., Baldi, F., Budillon, G., Cimino, L., Di Carlo, A., Di Marino, M.P., Morisco, F., Picciotto, F., Terracciano, L., Vecchione, R., Verde, V., Del Vecchio Blanco, C., Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J. Hepatol. 35:5 (2001), 568–574.
147. Benzie, I.F., Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int. J. Food Sci. Nutr. 47:3 (1996), 233–261.
148. Tanikava, K., Torimura, T., Studies of oxidative stress in liver disease: important trends in liver resrarch. Med. Mol. Morphol. 39 (2006), 22–27.
149. Enomoto, N., Takei, Y., Hirose, M., Ikejima, K., Miwa, H., Kitamura, T., Sato, N., Talidomid prevent alcoholic liver injury in rats through suppression of Kupffer cells sensitation and TNF –a production. Gastroenterology 123 (2002), 291–300.
150. Ratziu, V., Giral, P., Charlptte, F., Bruckert, E., Thibault, V., Teodorou, I., Khalil, L., Turpin, G., Opolon, P., Poynard, T., Liver fibrosis in overweight patients. Gastroenterology 118 (2000), 1117–1123.
151. Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y.J., Lang, L., Fukuda, T., Yamashina, S., Kitamura, T., Sato, N., Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 122:5 (2002), 1399–1410.
152. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-a direct role in obesity-linked insulin resistence. Science 259 (1993), 87–91.
153. Steppan, C.M., Baily, S.T., Bhat, S., Brovn, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Alima, R.S., Lazar, M.A., The hormone resistin links obesity to diabetes. (292) Nature, 409, 2001, 292 (292).
154. Shulman, G.I., Cellular mechanism of insulin resistence. J. Clin. Invest. 106 (2000), 171–176.
155. Pietrangelo, A., Iron in NASH, chronic liver diseases and HCC: how much iron is too much?. J. Hepatol. 50 (2009), 249–251.
156. Sumida, Y., Yoshikawa, T., Okanoue, T., Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol. Res. 39 (2009), 213–222.
157. Mori, M., Hattori, A., Sawaki, M., Tsuzuki, N., Sawada, N., Oyamada, M., Sugawara, N., Enomoto, K., The lac rat: a model of human hepatitis, liver cancer, and much more. Am. J. Parhol. 144 (1994), 200–204.
158. Marquez-Quinones, A., Cipak, A., Zarkovic, K., Fattel-Fazenda, S., Villa-Trevino, S., Waeg, G., Zarkovic, N., Gueraud, F., HNE-protein adducts formation in different pre-cancerogenic stage of hepatitis in lac rats. Free Radic. Res. 44 (2010), 119–127.
159. Niemela, O., Parkkila, S., Briton, R.S., Brunt, E., Janney, C., Bacon, B., Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury. J. Lab Med. 133 (1999), 451–460.
160. Li, C.J., Nanji, A.A., Siakotos, A.N., Lin, R.C., Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in liver of rats with alcoholic liver disease. Hepatology 26 (1997), 650–657.
161. Sampey, B.P., Korourian, S., Ronis, M.J., Badger, T.M., Petersen, D.R., Immunohistochemical characterisation of hepatic malondialdehyde and 4-hydoxynonenale modified proteins during early stage of ethanol-induced liver injury. Alcohol Clin. Exp. Res. 27 (2003), 1015–1022.
162. Poli, G., Biasi, F., Leonarduzzi, G., 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol. Asp. Med. 29 (2008), 67–71.
163. Seki, S., Kitada, T., Sakaguachi, H., Nakatani, K., Wakasa, K., Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology 42 (2003), 365–371.
164. Ong, W.Y., Jenner, A.M., Pan, N., Ong, C.N., Halliwell, B., Elevated oxidative stress, iron accumulation around microvessels and increased 4-hydroxynonenal immunostaining in zone 1 of the liver acinus in hypercholesterolemic rabbits. Free Radic. Res. 43 (2009), 241–249.
165. Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., Wakasa, K., In situ lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J. Hepatol. 37 (2002), 56–62.
166. Paradis, V., Mathurin, P., Kolinger, M., Imbert-Bismut, F., Charlotte, F., Piton, A., Opolon, P., Holstege, A., Poynard, T., Bedossa, P., In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J. Clin. Pathol. 50 (1997), 401–406.
167. Zhong, H., Xiao, M., Zarkovic, K., Zhu, M., Sa, R., Lu, J., Tao, Y., Chen, Q., Xia, L., Cheng, S., Waeg, G., Zarkovic, N., Huiyong in mitochondrial control of apoptosis through modulation of cardiolipin oxidation in hepatocellular carcinoma: a novel link between oxidative stress and cancer. Free Radic. Biol. Med. 102 (2017), 67–76.
168. Sanders, L.M., Henderson, C.E., Hong, M.Y., Barchoumii, R., Burghart, R.C., Carrol, R.J., Turner, N.D., Chapkin, R.S., Lupton, J.R., Pro-oxidant environmental of colon compared to the small intestine may contribute to grater cancer susceptibility. Cancer Lett. 208 (2004), 155–161.
169. Biasi, F., Leonarduzzi, G., Oteiza, P.I., Poli, G., Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid. Redox Signal. 19 (2013), 1711–1747.
170. Curran, F.T., Allan, R.N., Keighley, M.R., Superoxide production by Crohn's disease neutrophils. Gut 32 (1991), 399–402.
171. Beltran, B., Nos, P., Dasi, F., Iborra, M., Bastida, G., Martinez, M., O'Connor, J.E., Saez, G., Moret, I., Ponce, J., Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease. Inflamm. Bowel Dis. 16 (2010), 76–86.
172. Yasukava, K., Tokuda, H., Tun, X., Utsumi, H., Yamada, K., The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic. Res. 49 (2012), 1427–1436.
173. Lamm, M.E., Interaction of antigens and antibiotics at mucosal surface. Annu. Rev. Microbiol. 51 (1997), 311–340.
174. Kono, H., Fujii, H., Asakawa, M., Maki, A., Amemiya, H., Hirai, Y., Matsuda, M., Yamamoto, M., Medium-chain triglycerides enhance secretion og IgA expression in rat intestine after administration of endotoxin. Am. J. Phisiol. Gastrointest. Liver Physiol. 286 (2004), G1081–G1090.
175. Kimura, H., Lui, S., Yamada, S., Uchida, K., Matsumoto, K., Mukaida, M., Yoshida, K., Rapid increase in serum lipid peroxide 4-hydroxynonenal(HNE) trough monocite NADPH oxidase in early endo-toxemia. Free Radic. Res. 39 (2004), 845–851.
176. Kimura, H., Mukaida, M., Kuwabar, K., Ito, T., Hashino, K., Uchida, K., Matsumoto, K., Yoshida, K., 4-Hydroxynonenal modified IgA in rat intestine after lipopolysavvharide injection. Free Radic. Biol. Med. 41 (2006), 973–978.
177. Yelisyeyeva, O., Cherkas, A., Zarkovic, K., Semen, K., Kaminskyy, D., Waeg, G., Zarkovic, N., The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic. Res. 42 (2008), 205–211.
178. Cherkas, A., Yelisyeyeva, O., Semen, K., Zarkovic, K., Kaminsky, D., Cipak Gasparovic, A., Jaganjac, M., Lutsyk, A., Waeg, G., Zarkovic, N., Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Coll. Antropol. 3 (2009), 815–821.
179. Zwolinska-Weislo, M., Brzozowski, T., Ptak-Belowska, A., Targost, A., Urbanczyk, K., Kwiecien, S., Sliwowski, Z., Nitric oxide release aspirin bat not conventional aspirin improves healing of experimental colitis. World J. Gastroenterol. WJG 17 (2011), 4076–4089.
180. Sun, L., Wang, X., Yao, H., Li, W., Son, Y.O., Luo, J., Liu, J., Zhang, Z., Reactive oxygen species mediated Cr (VI)-induced S phase arrest through p53 in human colon cancer cells. J. Environ. Pathol. Toxicol. Oncol. 31 (2012), 95–107.
181. Kreuzer, T., Grube, R., Zarkovic, N., Schaur, R.J., 4-hydroxunonenal modified the effects of serum growth factors on the expression of the c-fos proto-oncogen and proliferation of HeLa carcinoma cells. Free Radic. Biol. Med. 25 (1998), 42–49.
182. Milkovic, L., Cipak Gasparovic, A., Zarkovic, N., Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth regulating factor. Free Radic. Res. 49 (2015), 850–860.
183. Kondo, S., Toyokumi, S., Iwasa, Y., Tanaka, T., Onodera, H., Hiai, H., Imamura, M., Persistent oxidative stres in human colorectal carcinoma, baut not in adenoma. Free Radic. Biol. Med. 27 (1999), 401–410.
184. Zarkovic, K., Uchida, K., Kolenc, D., Hlupic, L., Zarkovic, N., Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic. Res. 40 (2006), 543–552.
185. Biasi, F., Tessitore, L., Zanetti, D., Citrin, J.C., Zingaro, B., Chiarpotto, E., Zarkovic, N., Serviddio, G., Poli, G., Associated changes of lipid peroxidation and TGFβ1 levels in human cancer during tumor progression. Gut 50 (2002), 361–367.
186. Biasi, F., Vizio, B., Mascia, C., Gaia, E., Zarkovic, N., Chiarpotto, E., Leonarduzzi, G., Poli, G., JNK up-regulation as a key event in the pro-apoptotic interaction between TGF-ß1 and 4-hydroxynonenal in colon mucosa. Free Radic. Biol. Med. 40 (2006), 443–454.
187. Mrakovcic, L., Wildburger, R., Jaganjac, M., Cindric, M., Cipak, A., Sunjic, S.B., Waeg, G., Milankovic, A.M., Zarkovic, N., Lipid peroxidation product 4-hydroxynonenal as factor of oxidative homeostasis supporting bone regeneration with bioactive glasses. Acta Biochim. Pol. 57 (2010), 173–178.
188. Sunjic, S.B., Cipak, A., Rabuzin, F., Wildburger, R., et al. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. Biofactors 24:1–4 (2005), 141–148.
189. Borovic, S., Cipak, A., Meinitzer, A., Kejla, Z., Perovic, D., Waeg, G., Zarkovic, N., Differential effect of 4-hydroxynonenal on normal and malignant mesenchimal cells. Redox Rep. 207 (2007), 50–54.
190. Milkovic, L., Hoppe, A., Detsch, R., Boccaccini, A.R., Zarkovic, N., Effects of Cu-doped 45S5 bioactive glass on the lipid peroxidation-associated growth of human osteoblast-like cells in vitro. J. Biomed. Mater. Res.: Part A 102 (2014), 3556–3561.
191. Rudic, M., Wagner, R., Willkinson, E., et al. The lack of 4-hydroxynonenal in otosclerotic bone tissue in Ethiopian population. Eur. Arch. Otorhinolaryngol. 272:10 (2015), 2783–2789.
192. Rudic, M., Milković, L., Žarković, K., et al. The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis. Free Radic. Biol. Med. 57 (2013), 22–28.
193. Okamoto, K., Toyokuni, S., Uchida, K., et al. Formation of 8-hydroxy-2-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int.J. Cancer 58 (1994), 825–829.
194. Oberley, T.D., Toyokuni, S., Szweda, A.I., Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. Free Radic. Biol. Med. 27:5–6 (1999), 695–703.
195. Yilmaz, M.I., Saglam, K., Sonmez, A., Gok, D.E., Basal, S., Kilic, S., Akay, C., Kocar, I.H., Antioxidant system activation in prostate cancer. Biol. Trace Elem. Res. 98 (2004), 13–19.
196. Przybyszewski, W.M., Rzeszowska-Wolny, J., Oxidative stress in prostate hypertrophy and carcinogenesis. Postepy Hig. Med. Dosw. 63 (2009), 340–350.
197. Custovic, Z., Zarkovic, K., Cindric, M., Cipak, A., et al. Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic. Res. 44 (2010), 497–504.
198. Tabor, C.W., Tabor, H., Bachrach, U., Identifi cation of the ami- noaldehydes produced by the oxidation of spermine and spermidine with purifi ed plasma amine oxidase. J. Biol. Chem. 239 (1964), 2194–2203.
199. Rudra, P.K., Krokan, H.E., Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells. Anticancer Res. 19 (1999), 461–469.
200. Howie, A.F., Walker, S.W., Akesson, B., Arthur, J.R., Beckett, G.J., Thyroidal extracellular glutathione peroxidise: a potential regulator of thyroid-hormone synthesis. Biochem. J. 308:Pt 3 (1995), 713–717.
201. Young, O., Crotty, T., O Connell, R., et al. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 32 (2010), 750–756.
202. Jin, H., Zangar, R.C., Protein modifications as potential biomarkers in breast cancer. Biomark. Insights, 2009, 191–200.
203. Yao-Ping, L., Fu-Guo, T., Peng-Cheng, S., et al. 4-Hydroxynonenal promotes growth and angiogenesis of breast cancer cells through HIF-1ɑ stabilization. Asian Pac. J. Cancer Prev. 15 (2014), 10151–10156.
204. Karihtala, P., Kauppila, S., Puistola, U., JukkolaVuorinen, A., Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2nonenal (HNE) in breast carcinogenesis. Histopathology 58 (2011), 854–862.
205. Rajneesh, C.P., Manimaran, A., Sasikala, K.R., Adaikappan, P., Lipid peroxidation and antioxidant status in patients with breast cancer. Singap. Med. J. 49 (2008), 640–643.
206. Abou Ghalia, A.H., Fouad, I.M., Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases. Clin. Biochem. 33 (2000), 657–662.
207. Sova, H., Jukkola-Vuorinen, A., Puistola, U., Kauppila, S., Karihtala, P., 8-hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br. J. Cancer 102 (2010), 1018–1023.
208. Jakovcevic, D., Dedic- Pavletić, N., Vrbanec, D., Jakovcevic, A., Jakic-Razumovic, J., Breast Cancer Molecular Subtypes and Oxidative DNA Damage. Appl. Immunohistochem. Mol. Morphol. 23:10 (2015), 696–703.
209. Ciencewicki, J., Trivedi, S., Kleeberger, S.R., Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 122:3 (2008), 456–468.
210. British Thoracic Society, Guidelines for the management of chronic obsynthesis in lung inflammation. Thorax 52 (1997), S1–S28.
211. Rahman, I., MacNee, W., Role of oxidants/antioxidants in smoking-induced. Free Radic. Biol. Med. 21 (1996), 669–681.
212. Rahman, I., van Schadewijk, A.A., Crowther, A.J., Hiemstra, P.S., Stolk, J., MacNee, W., et al. 4-Hydroxy-2nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166 (2002), 490–495.
213. Gęgotek, A., Nikliński, J., Žarković, N., Žarković, K., Waeg, G., Łuczaj, W., Charkiewicz, R., Skrzydlewska, E., Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells. Redox Biol. 9 (2016), 210–219.
214. Muller, A., Cadanas, E., Graf, P., Sies, H., A novel biologically active seleno-organic compaund- glutation peroxidase- like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem. Pharmacol. 33 (1984), 3235–3239.
215. Lupachyk, S., Shevalye, H., Maksimichyk, J., Drel, V.R., Obrosova, I.G., PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adducts accumulation: correlation with peripheral nerve function. Free Radic. Biol. Med. 50 (2011), 1400–1409.
216. Sharma, S., Ying, Z., Gomez-Pinilla, F., A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma. Exp. Neurol. 226 (2010), 191–199.